A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia
Status:
Completed
Trial end date:
2019-03-10
Target enrollment:
Participant gender:
Summary
This is a Phase III, randomized, double-blind, propofol-controlled, parallel-design,
multi-center study to evaluate the efficacy and safety of HSK3486 for sedation or anesthesia
in patients undergoing colonoscopy and gastroscopy.
The study will enroll approximately 280 adults. The maximum study duration is anticipated to
be up to nine months.
Phase:
Phase 3
Details
Lead Sponsor:
Sichuan Haisco Pharmaceutical Group Co., Ltd Sichuan Haisco Pharmaceutical Group Co., Ltd.